Childbearing issues in breast carcinoma survivors

Cancer

Volumn 79, Issue 7, 1997, Pages 1271-1278

  Surbone, Antonella ^a   Petrek, Jeanne A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

breast carcinoma; chemotherapy induced infertility; pregnancy; survival

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN; FLUOROURACIL; MELPHALAN; METHOTREXATE; TAMOXIFEN;

ADOPTION; AMENORRHEA; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DOCTOR PATIENT RELATION; ESTROGEN THERAPY; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; MENOPAUSE; PREGNANCY; PRIORITY JOURNAL; REVIEW; TUMOR PROMOTION;

BREAST NEOPLASMS; ESTROGENS; FEMALE; HUMANS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; SURVIVORS;

EID: 0030945260     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970401)79:7<1271::AID-CNCR1>3.0.CO;2-K     Document Type: Review

References (62)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-29.
2. Ventura SJ. First births to older mothers 1970-1986. Am J Public Health 1989;79:1675-84.
3. Kelsey JL, Berkowitz GS. Breast cancer epidemiology. Cancer Res 1988;48:5615-23.
4. Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment. Lancet 1896;2:104-7, 162-5.
5. Early Breast Cancer Trialist Collaborative Group. Systemic treatment of early breast carcinoma by hormonal, cytotoxic, or immune therapy. Lancet 1992;339(i):71-85.
6. Danforth DN. How subsequent pregnancy affects outcome in women with a prior breast cancer. Oncology 1991;11:23-9.
7. Welsch CW. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 1985;45:3415-43.
8. Osborne CK, Arteaga CL. Autocrine and paracrine growth regulation of breast cancer: clinical implications. Breast Cancer Res Treat 1990;15:3-11.
9. Harris JR, Morrow M, Bonadonna G. Cancer of the breast. In: DeVita VT, Hellman S, Rosenberg SA. editors. Cancer: principles and practice of oncology. 4th edition. Philadelphia: J.B. Lippincott Co., 1993:1264-1332.
10. Fisher B, Osborne CK, Margolese R, Bloomer W. Neoplasms of the breast. In: Holland JF, Frei E (III), Bast RC, Kufe DW, Morton DL, Weichselbaum RR, editors. Cancer medicine. 3rd edition. Philadelphia: Lea & Febiger, 1993:1706-75.
11. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
12. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habal LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995;274(2):137-41.
13. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Etttinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117:1016-37.
14. Grady D, Cummings SR, Petitti D, Rubin SM, Audet AM. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 1992; 117:1038-41.
15. Cobleigh MA, Berris RF, Bush T, Davidson NE, Robert NJ, Sparano JA, et al. Estrogen replacement therapy in breast cancer survivors: a time for change. JAMA 1994;272:540-5.
16. Dhodapkar MV, Ingle JN, Ahmann DL. Estrogen replacement therapy withdrawal and regression of metastatic breast cancer. Cancer 1995;75:43-6.
17. Senie RT, Kinne DW. Menstrual timing of treatment for breast cancer. Monogr Natl Cancer Inst 1994;16:85-90.
18. Davidson NE, Abeloff MD. Menstrual effects on surgical treatment for breast cancer. Cancer Treat Rev 1993;19:105-12.
19. Gallenberg MM, Loprinzi CL. Breast cancer and pregnancy. Semin Oncol 1989;16:369-76.
20. Petrek JA. Breast cancer during pregnancy. Cancer 1994; 74:518-27.
21. Guinee VF, Olsson H, Moller T, Hess KR, Taylor SH, Fahey T, et al. Effect of pregnancy on prognosis for young women with breast cancer. Lancet 1994;343:1587-9.
22. von Schoultz E, Hemming J, Wilking N, Rutqvist LE. Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 1995;13:430:11-8.
23. Read LD, Greene GL, Katzenellenbogen BS. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol Endocrinol 1989;3:295-304.
24. Sakai F, Saez S. Existence of receptors bound to endogenous estradiol in breast cancers in premenopausal and postmenopausal women. Steroids 1976;27:99-110.
25. Elledge RM, Ciocca DR, Langone G, Mcguire WL. Estrogen receptor, and her-2/neu protein in breast cancers from pregnant patients. Cancer 1993;71:2499-2506.
26. Higgins S, Haffty BG. Pregnancy and lactation after breast-conserving therapy for early stage breast cancer. Cancer 1994;73:2175-80.
27. Petrek JA. Pregnancy safety after breast cancer. Cancer 1994;74(1):528-31.
28. Harvey JC, Rosen PP, Ashikari H, Robbins GF, Kinne DW. The effect of pregnancy on the prognosis of carcinoma of the breast following radical mastectomy. Surg Gynecol Obstet 1981;153:723-5.
29. Mignot L, Morvan F, Berdah J. Pregnancy after breast cancer: results of a case-control study. Presse Med 1986;15:1961-4.
30. Ariel I, Kempner R. The prognosis of patients who become pregnant after mastectomy for breast cancer. Int Surg 1989;74:185-7.
31. Clark RM, Chua T. Breast cancer and pregnancy: the ultimate challenge. Clin Oncol R Coll Radiol 1989;1:11-8.
32. Sutton R, Buzdar AU, Hortobagyi GN. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer 1990;65:847-50.
33. Donegan WL. Breast cancer and pregnancy. Obst Gynecol 1977;50:244-52.
34. Peters MV. Carcinoma of the breast associated with pregnancy. Radiology 1962;78:58-67.
35. Ribiero G, Jones DA, Jones M. Carcinoma of the breast associated with pregnancy. Br J Surg 1986;73:607-9.
36. Cooper DR, Butterfield J. Pregnancy subsequent to mastectomy for cancer of the breast. Ann Surg 1970;171:429-33.
37. Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: "healthy mother effect." Am J Obstet Gynecol 1994;170:818-23.
38. McCormick GM, Moon RC. Effect of pregnancy and lactation on growth of mammary tumors induced by 7,12-dimethylibenz (A)-anthracene (DMBA). Br J Cancer 1965;19:160-8.
39. Lemon HM. Antimammary carcinogenic activity of 17-alpha-ethinyl estriol. Cancer 1987;60:2873-81.
40. Lemon HM, Kumar PF, Peterson C, Rodriquez-Sierra JF, Abbo KM. Inhibition of radiogenic mammary carcinoma in rats by estriol or tamoxifen. Cancer 1989;63:1685-92.
41. Morgenfeld MC, Goldberg V, Parisier H, Bur GE, Bugnard SC. Ovarian lesions due to cytostatic agents during the treatment of Hodgkin's disease. Surg Gynecol Obstet 1972; 134:826-8.
42. Hortobagyi GN, Buzdar AU, Marcus CE, Smith TL. Immediate and long term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute. Monogr Natl Cancer Inst 1986;1:105-9.
43. Dinistrian AM, Schwartz MK, Fracchia AA, Kaufman RJ, Hakes TB, Currie VE. Endocrine consequences of CMF therapy in premenopausal and postmenopausal breast cancer patients. Cancer 1983;51:803-7.
44. Schilsky RL, Lewis BJ, Sherins RJ, Young RC. Gonadal dysfunction in patients receiving chemotherapy for cancer. Ann Intern Med 1980;93:109-14.
45. Reichman B, Green KB. Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects. Monogr Natl Cancer Inst 1994;16:125-9.
46. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal woment treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14:1718-29.
47. Damewood MD, Grochow LB. Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril 1986;45:443-59.
48. Brincker H, Rose C, Rank F, Mouridsen HT, Jakobsen A, Dombernowsky P. Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer. J Clin Oncol 1987;5:1771-8.
49. Koyama H, Wada T, Nishizawa Y, Cappellini M, Isola G, Nenci I. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 1977;39:1403-9.
50. Boccardo F, Rubagotti A, Amoroso D, Sismondi P, Genta F, Nenci F, et al. Chemotherapy vs tamoxifen vs chemotherapy plus tamoxifen in node positive, estrogen receptor positive breast cancer patients: results of a multicentric Italian study. J Clin Oncol 1990;8:1310-20.
51. Love RR. Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects. J Clin Oncol 1989;7:803-15.
52. Collichio F, Pandya K. Amenorrhea following chemotherapy for breast cancer: effect on disease-free survival. Oncology 1994;8(12):45-52.
53. Mulvihill JJ, McKeen EA, Rosner F, Zarrabi MH. Pregnancy outcome in cancer patients. Cancer 1987;60:1143-50.
54. Bianco AR, De Mastro L, Gallo C, Perrone F, Malano E, Pagliarulo C, et al. Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer. Br J Cancer 1991;63:799-803.
55. Hussein EE, Tan SL. Successful in vitro fertilization and embryo transfer after treatment of invasive carcinoma of the breast. Fertil Steril 1992;58:194-6.
56. Carr JR, Wilson JD. Disorders of the ovary and female reproductive tract. In: Jeffers JD, Boynton SD, editors. Harrison's principles of internal medicine. New York: McGraw-Hill, Inc., 1994: 2017-30.
57. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992;136:1204-11.
58. Rossing MA, Daling JR, Weiss NS, More DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331(12)771-6.
59. Kaufman SC, Spirtas R, Alexander N. Do fertility drugs cause ovarian tumors? J Women's Health 1995;4:247-59.
60. Sauer MV, Paulson R, Lobo R. Reversing the natural decline in human fertility: an extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA 1992;268:1320-1.
61. Sauer MV, Paulson RJ, Lobo RA. Successful pre-embryo donation in ovarian failure after treatment for breast carcinoma. Lancet 1990;335:723.
62. Petrek JA. Menstrual cycle maintenance and quality of life after breast cancer treatment: a prospective study. Grant DAMD 17-96-1-6292 awarded by the U.S. Army Medical Research and Materiel Command. Fort Detrick, MD.